7-97990089-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006188.4(OCM2):c.16G>A(p.Val6Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000547 in 1,609,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006188.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 23AN: 151556Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.000131 AC: 33AN: 251408Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135890
GnomAD4 exome AF: 0.0000446 AC: 65AN: 1457886Hom.: 0 Cov.: 35 AF XY: 0.0000400 AC XY: 29AN XY: 725316
GnomAD4 genome AF: 0.000152 AC: 23AN: 151672Hom.: 0 Cov.: 29 AF XY: 0.000189 AC XY: 14AN XY: 74124
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2023 | The c.16G>A (p.V6M) alteration is located in exon 1 (coding exon 1) of the OCM2 gene. This alteration results from a G to A substitution at nucleotide position 16, causing the valine (V) at amino acid position 6 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at